Global Spine Biologics Market Size By Product (Bone Graft Substitutes, Spinal Allografts), By End User (Hospitals, Ambulatory Surgical Center), By Geographic Scope And Forecast
Published Date: July - 2024 | Publisher: MIR | No of Pages: 320 | Industry: latest updates trending Report | Format: Report available in PDF / Excel Format
Spine Biologics Market size was valued at USD 3.72 Billion in 2021 and is projected to reach USD 16.2 Billion by 2030, growing at a CAGR of 17.5% from 2023 to 2030.
Factors driving market expansion include an increase in the ageing population, advantages of biologics such as minimal postoperative time, faster recovery, and their capacity to activate cellular growth. The Global Spine Biologics Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Global Spine Biologics Market Definition
Spine biologics are materials that change the environment around them via active biological processes. They contribute in damage repair and healing by promoting growth and differentiation. They also lessen the need for primary or secondary surgical treatments, as well as soft tissue disruption. A wide range of spine biologics is currently employed as an alternative to traditional therapy. Pedicle screws and rods, for example, are used in spine fusion procedures to offer spinal stability and promote recovery. Furthermore, constant breakthroughs are supporting cartilaginous and bone structural repair and regeneration.
Biologics are the most recent therapy options in clinical trials, especially in orthopaedic surgery. Spine biologics are biomaterials that change the environment through active biological processes that stimulate development and differentiation, assisting in the repair and healing of an injury or other ailment. Some biologics are intended to replace a person’s natural bone graft, while others that encourage cartilaginous and bony structure repair and regeneration are still in the early stages of development.
What's inside a industry report?
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
Global Spine Biologics Market Overview
Spine biologics? Think of them as helpers for your back, used in surgeries to fix things like trauma, tumors, worn-out discs, and even damage to the spinal cord during spine fusion. What's making them popular? Well, more older folks need them, and biologics are pretty great – they can mean less time in the hospital after surgery, quicker healing, and they even encourage cells to grow! But, there are some downsides. Getting insurance to pay can be tough, bone grafts aren't cheap, and some people have ethical questions about where the bone comes from. Still, these biologics help bones grow in three key phases – inflammation, repair, and remodeling – so as spinal fusion surgery becomes more common, so does the use of these little helpers.
As we get older, and the senior population grows, expect a bigger need for biologics. After all, who doesn't want relief from things like spinal stenosis? It's a common issue for folks over 50, regardless of gender. Aging can really do a number on your spine, causing structural changes like thickening tissues and enlarged bones and joints, ultimately leading to problems. Thankfully, spine biologics are offering some hope, promising quicker recovery, less time in the hospital after surgery, and even the possibility of boosting cellular growth – all fueling growth in the market! And, let's be honest, who wants more spinal issues due to enlarged bones and tissue thickening? This is a major reason why the market is expanding. For those with serious spinal abnormalities, spinal fusion surgery might be the answer, further driving demand. Of course, it's not all smooth sailing. Rising costs for bone grafts, a tough reimbursement situation, and worries about bone grafting procedures could slow things down for the spine biologics industry.
Global Spine biologics MarketSegmentation Analysis
The Global Spine Biologics Market is segmented on the basis of Product, End User, and Geography.
Spine Biologics Market, By Product
Bone Graft Substitutes
Spinal Allografts
Others
Based on the Product, the market is bifurcated into Bone Graft Substitutes, Spinal Allografts, and Others. Spinal allografts are expected to expand in popularity in the future, thanks to a number of advantages associated with their use. Spinal allografts are allograft bone from another patient (donor) that is used in the spine therapy method. The use of allografts in spinal fusion will avoid the need for a second operation, resulting in a shorter recovery period.
Spine Biologics Market, By End User
Hospitals
Ambulatory Surgical Center
Others
Based on the End User, the market is bifurcated into Hospitals, Ambulatory Surgical Center, and Others. The section of hospitals is mostly driven by the increased number of spine fusion surgery conducted in these facilities. High hospitalization costs, on the other hand, have resulted in fewer patient admissions to hospitals, but the number of outpatient visits has increased. Over the projected period, this is likely to pose a threat to the deployment of spine biologics in hospital settings.
Spine Biologics Market, By Geography
North America
Europe
Asia Pacific
Rest of the world
On the basis of Regional Analysis, the Global Spine Biologics Market is classified into North America, Europe, Asia Pacific, and Rest of the world. Because of its consistent economic growth, increased prevalence of spine ailments such as spinal stenosis, disc-related difficulties, and spondylolisthesis, and high adoption of minimally invasive operations, North America dominates the Spine Biologics Market.
Key Players
The “Global Spine Biologics Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Johnson & Johnson (Depuy Synthes), Orthofix Medical Inc., Stryker Corporation, Zimmer Biomet, Arthrex, Inc., Exactech, Inc, Wright Medical Technology Inc., Medtronic Inc, DePuy Synthes Companies, K2M Inc., Nuvasive Inc. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
Report Scope
REPORT ATTRIBUTES
DETAILS
STUDY PERIOD
2018-2030
BASE YEAR
2021
FORECAST PERIOD
2023-2030
HISTORICAL PERIOD
2018-2020
UNIT
Value (USD Billion)
KEY COMPANIES PROFILED
Johnson & Johnson (Depuy Synthes), Orthofix Medical Inc., Stryker Corporation, Zimmer Biomet, Arthrex, Inc., Exactech, Inc, Wright Medical Technology Inc., & Others
SEGMENTS COVERED
By Product
By End User
By Geography
CUSTOMIZATION SCOPE
Free report customization (equivalent to up to 4 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope.
Top Trending Reports
Research Methodology of Market Research
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .
Reasons to Purchase this Report
We'll dig into the market using both qualitative and quantitative methods, slicing and dicing it by economic and, well, everything else. Expect hard numbers – market value in USD Billion – for every segment and sub-segment. We'll point out which region and segment are set to explode with growth and who's king of the hill. Plus, we'll break down each region, looking at product/service use and the factors influencing the local market. See who's on top with a competitive landscape view, complete with market rankings, new service/product drops, alliances, expansions, and acquisitions from the last five years. Get the lowdown on key players with company profiles covering overviews, insights, product comparisons, and SWOT analysis. Understand where the market is heading, considering recent happenings, growth potential, drivers, hurdles, and limitations in both up-and-coming and established areas. We'll also dive deep with Porter's five forces analysis, map out the Value Chain, explore market dynamics, pinpoint growth opportunities in the future, and even throw in 6 months of post-sales support from our analysts.
Customization of the Report
• In case of any please connect with our sales team, who will ensure that your requirements are met.
For a single, multi and corporate client license, the report will be available in PDF format.
Sample report would be given you in excel format. For more questions please contact:
Sample Report for Global Spine Biologics Market Size By Product (Bone Graft Substitutes, Spinal Allografts), By End User (Hospitals, Ambulatory Surgical Center), By Geographic Scope And Forecast